-
-
Call more information
660-596-2224 -
Authors: Maarten van Lemmen, B.Sc. et al Anesthesiology February 2024. In Reply: We thank Dr. Pattullo and Drs. Milas and Varon for their interest and careful reading of our article on the use of naloxone in the reversal of an opioid overdose as might occur in the community setting in the United States. Individuals that […]
Read MoreAuthor: Gavin G. Pattullo, F.A.N.Z.C.A., F.F.P.M.A.N.Z.C.A. Anesthesiology February 2024. To the Editor: As clinicians, we often question why some patients respond to naloxone and others do not when opioid-induced ventilatory impairment is suspected. This inexplicability is disconcerting, given the toll of opioid-induced ventilatory impairment–related deaths. Our search for greater understanding, as recently provided in this […]
Read MoreAuthora: Bonnie L. Milas, M.D. et al Anesthesiology February 2024. To the Editor: As ASA members spearheading the REVIVEme.com initiative, we appreciate the thorough review of naloxone’s pharmacokinetics and dynamics by Lemmen et al. and the focus it brings to our Journal’s readers. It is clear that further study of opioid overdose reversal of respiratory depression […]
Read MoreAuthor: Rebecca Pifer HealthcareDive Arbiters are mostly selecting the higher payment offer in billing dispute determinations. That suggests No Surprises could actually raise premiums for consumers, one health researcher said. Dive Brief: The federal government received 13 times more surprise billing disputes in the first half of 2023 than it expected to receive in a […]
Read MoreAUTHOR: ARTHUR LAZARUS, MD, MBA KevinMD.com Following a Congressional hearing into antisemitic harassment on the campuses of Harvard, MIT, and the University of Pennsylvania, there were several changes in leadership at Penn. Jonathan A. Epstein, MD, was named interim dean at Penn’s Perelman School of Medicine, replacing J. Larry Jameson, MD, PhD, who became interim […]
Read More